Health & Environmental Research Online (HERO)


Print Feedback Export to File
3749278 
Journal Article 
Effects of perfluorinated alkyl acids on cellular responses of MCF-10A mammary epithelial cells in monolayers and on acini formation in vitro 
Halsne, R; Tandberg, JI; Lobert, VH; Østby, GC; Thoen, E; Ropstad, E; Verhaegen, S 
2016 
Toxicology Letters
ISSN: 0378-4274
EISSN: 1879-3169 
Elsevier 
259 
Elsevier 
95-107 
English 
is supplemented by 3982038 : Supplementary materials
Perfluorinated alkyl acids (PFAAs) are stable chemicals detected in tissue and serum from various species, including humans, and have been linked to adverse health outcomes. Experimental PFAA exposure in rodents has been associated with changes in mammary gland development. The estrogen receptor (ER)-negative human breast epithelial cell line, MCF-10A, can be grown as monolayer, but also has the ability to form three-dimensional acini in vitro, reflecting aspects of mammary glandular morphogenesis. Cells were exposed to five different PFAAs, perfluorooctane sulfonate (PFOS), perfluorooctanoic acid (PFOA), perfluorononanoic acid (PFNA), perfluorodecanoic acid (PFDA), and perfluoroundecanoic acid (PFUnDA), both in monolayer and acini cultures. In monolayer cultures only the higher concentrations of PFOS, PFNA and PFDA (400-500μM) caused a significant increase in cell death, whereas PFOA and PFUnDA had no effect. Normal acini maturation was negatively impacted by PFOS, PFNA and PFDA already at the lowest concentration tested (0.6μM). Observed effects included loss of organization of the cell clusters and absence of a hollow lumen. Overall, this study demonstrated that PFAAs can interfere with cellular events related to normal development of glandular breast tissue through ER-independent mechanisms. 
Persistent organic pollutants; Epithelial polarisation; beta-Catenin; GM130; Perfluorooctane sulfonate; Perfluorooctanoic acid; Perfluorononanoic acid; Perfluorodecanoic acid; Perfluoroundecanoic acid 
PFAS
• Additional PFAS (formerly XAgency)
     Literature Search November 2019
          Other Sources
               Reference list review of included studies
               TEDX
     Screened Studies
          Excluded
               Exclude (TIAB)
• Expanded PFAS SEM (formerly PFAS 430)
     Litsearch: September 2019
          PubMed
          Web of Science
          Other Sources
               PFAS TOX Database
     Screened Studies
          Excluded
               Exclude (TIAB)
     Not prioritized for screening
     Perfluorooctane
• ^Per- and Polyfluoroalkyl Substances (PFAS)
     PFOA (335-67-1) and PFOS (1763-23-1)
          Literature Search – Adverse outcome pathway (2015-present)
               Pubmed
               WOS
     PFUnA (2058-94-8)
          Literature Search
               Pubmed
               WOS
     PFDA (335-76-2)
          Literature Search
               Pubmed
               WOS
     PFNA (375-95-1)
          Literature Search
               Pubmed
               WOS
• PFAS 150
     Literature Search Update December 2020
          PubMed
          WOS
     Literature Search August 2019
          PubMed
          Web of Science
          Other sources
               PFAS TOX Database
     Screened Studies
          Supplemental
     Ammonium perfluorooctanoate
     Perfluorodecanoic acid
     Perfluorononanoic acid
     Perfluorooctane
     Perfluorooctanesulfonic acid
     Perfluorooctanoic acid
     Perfluoroundecanoic acid
• PFAS Universe
     Data Source
          Web of Science
          Pubmed
     Ammonium perfluorooctanoate
     Perfluorodecanoate
     Perfluorodecanoic acid
     Perfluorononanoic acid
     Perfluorooctane
     Perfluorooctanesulfonate
     Perfluorooctanesulfonic acid
     Perfluorooctanoate
     Perfluoroundecanoate
     Perfluoroundecanoic acid
     Perfluorooctanoic acid
• PFDA
     Literature Search
          Pubmed
          WOS
          Other
               Published PFAS SEMs
     Scopus: April 2021
     Screening Results
          In vitro/ex vivo/in silico
               Receptor activation
               Other mechanistic studies
     Title and Abstract Screening
          Full Text Screening
          Tagged as Supplemental
               Mechanistic or MOA
     June 2022 Pelch Database
     Literature Searches (through April 2023 update and post-public comment/peer review)
          Title & Abstract Screening
               Full Text Screening
               Tagged as Supplemental
                    In vitro and in silico models
• PFNA
     Literature Search (August 2017)
          Pubmed
     Litsearch Update 2017-2018
          Toxline
     Litsearch Addl Synonyms 2018
          Toxline
          WOS
     PFNA Literature Search pre-2019
          Pubmed
          WOS
     Literature Search
          Pubmed
          Toxline
          WOS
     Screening Results
          In vitro/ex vivo/in silico
               Endocrine disruption
     Title and Abstract Screening
          Full Text Screening
          Tagged as Supplemental
               Mechanistic or MOA
     June 2022 Pelch Database
• PFUnA
     Literature Search
          Pubmed
          WOS
     Screening Results
          In vitro/ex vivo/in silico
               Other mechanistic studies
OW - HHRAB
• PFOA (335-67-1) and PFOS (1763-23-1)
     Literature Search – Adverse outcome pathway (2015-present)
          Pubmed
          WOS
     Screening Results
          In vitro/ex vivo/in silico
               Other mechanistic studies
     Literature Search Update (2013-2019)
          PubMed
          WOS